43742-2362 NDC - ENTEROCOCCUS FAECALIS, PNEUMOCOCCINUM, STREPTOCOCCUS AGALACTIAE, STREPTOCOCCUS AGALACTIAE DNA, STREPTOCOCCUS BOVIS, STREPTOCOCCUS DYSGALACTIAE, STREPTOCOCCUS DYSGALACTIAE DNA, STREPTOCOCCUS MUTANS, STREPTOCOCCUS MUTANS DNA, STREPTOCOCCUS ORALIS, STREPTOCOCCUS PNEUMONIAE , STREPTOCOCCUS PNEUMONIAE DNA, STREPTOCOCCUS UBERIS, STREPTOCOCCUS VIRIDANS

Drug Information

Product NDC: 43742-2362
Proprietary Name:
Non Proprietary Name: Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Agalactiae DNA, Streptococcus Bovis, Streptococcus Dysgalactiae, Streptococcus Dysgalactiae DNA, Streptococcus Mutans, Streptococcus Mutans DNA, Streptococcus Oralis, Streptococcus Pneumoniae , Streptococcus Pneumoniae DNA, Streptococcus Uberis, Streptococcus Viridans
Active Ingredient(s): 15 [hp_X]/mL ENTEROCOCCUS FAECALIS; 15 [hp_X]/mL HERRING SPERM DNA; 15 [hp_X]/mL STREPTOCOCCUS AGALACTIAE; 15 [hp_X]/mL STREPTOCOCCUS DYSGALACTIAE; 15 [hp_X]/mL STREPTOCOCCUS EQUINUS; 15 [hp_X]/mL STREPTOCOCCUS MUTANS; 15 [hp_X]/mL STREPTOCOCCUS ORALIS; 15 [hp_X]/mL STREPTOCOCCUS PNEUMONIAE; 15 [hp_X]/mL STREPTOCOCCUS UBERIS; 15 [hp_X]/mL STREPTOCOCCUS VIRIDANS GROUP
Administration Route(s):
Dosage Form(s): LIQUID

Labeler Information

Field Name	Field Value
Labeler Name:	Deseret Biologicals,Inc.
Product Type:	DRUG FOR FURTHER PROCESSING
FDA Application Number:
Marketing Category:	DRUG FOR FURTHER PROCESSING
Start Marketing Date:	12/19/2025

Package Information

No.	Package Code	Package Description	Billing Unit
1	43742-2362-1	3840 mL in 1 CONTAINER (43742-2362-1)

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	43742-2362	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAME	DRUG FOR FURTHER PROCESSING	Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
NON PROPRIETARY NAME	Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Agalactiae DNA, Streptococcus Bovis, Streptococcus Dysgalactiae, Streptococcus Dysgalactiae DNA, Streptococcus Mutans, Streptococcus Mutans DNA, Streptococcus Oralis, Streptococcus Pneumoniae , Streptococcus Pneumoniae DNA, Streptococcus Uberis, Streptococcus Viridans	The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAME	LIQUID	The translation of the dosage form Code submitted by the firm.
START MARKETING DATE	12/19/2025	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	DRUG FOR FURTHER PROCESSING	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAME	Deseret Biologicals,Inc.	Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAME	ENTEROCOCCUS FAECALIS; HERRING SPERM DNA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUINUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS UBERIS; STREPTOCOCCUS VIRIDANS GROUP	An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH	15; 15; 15; 15; 15; 15; 15; 15; 15; 15
ACTIVE INGRED UNIT	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL

Drug Information

Labeler Information

Package Information

NDC Record

Download Record